For Southeastern United States FamiliesDiabetic Foot Ulcer Not Healing — Cuba Treatment Options in Southeastern United States
The Southeastern United States — including Florida, Mississippi, Louisiana, South Carolina, and neighboring states — is home to over 1.1 million Americans living with Alzheimer's. This region has some of the highest Alzheimer's prevalence rates in the nation, driven by large senior populations, significant African American communities (who face disproportionately high dementia risk), and high diabetes rates that compound cognitive decline. Miami, Tampa, and Fort Lauderdale offer the most convenient direct charter flights to Havana, while Atlanta, Charlotte, and New Orleans provide connecting flight options.
7.0M
Southeastern United States residents with diabetes
6
states in region
1–5 hours (varies by departure city)
to Havana
Direct
flights available
When Standard Care Isn't Enough Across Southeastern United States
A diabetic foot ulcer that has not healed after 4+ weeks of standard wound care is classified as a chronic, non-healing ulcer. In the United States, treatment options for chronic ulcers are limited — typically involving advanced dressings, negative pressure wound therapy, or hyperbaric oxygen therapy, which may or may not be covered by insurance. For many patients, the next step is amputation.
Cuba offers a different option. Heberprot-P (recombinant human epidermal growth factor) is specifically designed for chronic, non-healing diabetic foot ulcers. The growth factor is injected directly into the wound bed, where it stimulates the cell proliferation and angiogenesis needed for healing — processes that are impaired in chronic diabetic wounds. Combined with comprehensive wound care (debridement, infection management, off-loading, vascular assessment), Heberprot-P offers a treatment option for ulcers that have not responded to standard U.S. care.
The program is not a cure, and outcomes vary based on wound severity, vascular status, infection control, and overall health. However, for American patients facing chronic, non-healing ulcers and the prospect of amputation, Cuba's comprehensive approach offers an additional treatment option worth exploring. A medical record review can determine whether Heberprot-P is appropriate for your specific case.
Heberprot-P is not FDA-approved and is not available in the United States. It is not a cure for diabetes. Treatment aims to promote wound healing and prevent amputation. Treatment suitability is determined after individual medical evaluation. Individual outcomes vary.
State-by-State Guides
Diabetic Foot Ulcer Not Healing — Cuba Treatment Options by State in Southeastern United States
Select your state for detailed information about diabetic foot ulcer not healing — cuba treatment options options, travel logistics, and state-specific resources.
City-Level Guides
Diabetic Foot Ulcer Not Healing — Cuba Treatment Options by City in Southeastern United States
Travel from Southeastern United States
Getting to Havana from Southeastern United States
Major Departure Airports
- Miami (MIA)
- Tampa (TPA)
- Fort Lauderdale (FLL)
- Atlanta (ATL)
- Charlotte (CLT)
- New Orleans (MSY)
Travel time: 1–5 hours (varies by departure city)
Travel Authorization
- • U.S. citizens can travel to Cuba under approved categories
- • SMC Salud provides letter of medical necessity
- • Treatment confirmation documentation included
- • Airport reception and ground transport in Havana
- • English-speaking coordinators throughout your stay
Frequently Asked Questions
Questions from Southeastern United States Families
Yes. U.S. citizens can travel to Cuba under approved categories. SMC Salud provides all necessary documentation, including the letter of medical necessity and treatment confirmation, to support travel authorization. Our team guides you through the entire process to ensure compliance with all regulations.
Ready to Explore Diabetic Foot Ulcer Not Healing — Cuba Treatment Options in Cuba?
Submit your medical records for a complimentary review. Families across Southeastern United States receive a personalized treatment proposal within 5–10 business days.